## 

## 

|Neil Mundy|||Interim Joint Chairman<br>to 31stJuly 2021||||
|---|---|---|---|---|---|---|
|Derek Bell|||Joint Chairman<br>from 1stSeptember 2021||||
|Julie Ann Gillon|||Chief Executive||||
|Anandapuram|Deepak Dwarakanath||Medical Director /Deputy<br>Chief Executive||||
|Alan Sheppard|||Chief People Officer||||
|Neil Atkinson|||Director ofFinance||||
|Graham<br>Evans<br>Lynne Taylor|||Chief Information<br>Technology<br>Otficer<br>Director of Planning 8 Performance<br>to 31stOctober 2021||||
|Barbara<br>Bright|||Director ofCorporate<br>Affairs and Chief ofStaffto 31st|March 2022|||
|Levi Buckley|||Chief Operating<br>Officer||||
|Stephen<br>Hall|||Vice Chairman<br>and Non-executive<br>Director||||
|Rite Taylor|||Non-executive<br>Director to 28th February 2022||||
|Jonathan<br>Erskine|||Non-executive<br>Director to 28th February 2022||||
|Kevin Robinson|||Non-executive<br>Director to 28th February 2022||||
|Philip Craig|||Non-execulive<br>Director lo 28th February 2022||||
|Ann Baxter|||Non-executive<br>Director||||
|Neil Schneider|||Associate Non-executive<br>Director to 14th April 2021||||
|Lindsey Robertson|||Director of Nursing,<br>Patient Safety and Duality||||
|Linda Hunter|||Interim<br>Director of Planning 6Pedormance<br>from 1stOctober 2021||||
|Graham<br>Walton|||Non-executive<br>Director from 1st March 2022||||
|Christopher<br>Macklin|||Non-executive<br>Director from 24th March 2022||||
|The Executive|Directors|and Non-executive<br>Directors ofthe Foundation<br>Trust Board are the Trustee of the Charily.|||||
|The<br>Executive|Directors|are appointed|by the<br>Non-executive<br>Directors<br>and<br>the<br>Governors|appoint|the|Non-|
|executive Directors.|||||||





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

|||||||||~Edi|E000|
|---|---|---|---|---|---|---|---|---|---|
|Paxman|cooling caps to prevent|||hair loss during chemotherapy|||treatment|35||
|Ornnicell|cabinet drugs dispenser|||||||33||
|Motomed|letto2 leg/arm<br>bed||model||ITU|||10||
|Mammography||biopsy mobile|chair|||||7||
|Portable|hand|held saturation|monitors,|||leads &probes Neonatal||6||
|Duo headlight||breast unit||||||5||
|Other medical||equipment||||||||
|||||||||107||





## 

## 

|jor refurbishments<br>a|nd IT equipme|nt<br>purchases<br>during the|year are shown|below:|||
|---|---|---|---|---|---|---|
|||||~E*|dtt|EDOD|
|HL7 Reporting<br>interface between||ICE & Unisoft Endoscopy|System||10||
|Brainomix - Software|||||9||
|Other refurbishment|costs||||||
||||||22||



|||||||~E*|dt|EDOD|
|---|---|---|---|---|---|---|---|---|
|Staff|training||||||35||
|Staff|recharge|room equipment,|external|work and garden|furniture||17||
|Other|staff welfare||||||17||
||||||||70||



## 

|||||~E*|dtt|EODD|
|---|---|---|---|---|---|---|
|Staff lottery|winnings|paid|||27||
|Staff lottery|administration||costs||1||
|Fundraising|Events|costs|||5||
|Fundraising|salary recharge costs||||22||
||||||55||





## 

## 

## 

## 

## 

## 



## 

## 

## 




## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 



## 

|Statement ofFinancia|l<br>Ac|tivi|ties for the ye|ar ended|31 March 2022||||
|---|---|---|---|---|---|---|---|---|
||||||||Total|Total|
|||||Note|Unrestricted|Restricted|Funds|Funds|
||||||Funds|Funds|2021/22|2020/21|
||||||E000|E000|6000|EOOO|
|Income and endowments||from:|||||||
|Donations||||3|398|100|498|547|
|Legacies||||3|161||161|16|
|Charitable<br>activities||||4||41|41|20|
|Other trading<br>activities-staff||lottery||5||40|43|17|
|Other incoming<br>resources||||6||5|5|66|
|Investment<br>Income||||13.3|20|21|41|40|
|Total incoming<br>resources|||||582|207|789|706|
|Expenditure<br>on:|||||||||
|Raising Funds|||||26|29|55|12|
|Charitable<br>activities:|||||||||
|Research Posts and Clinical||Care||||4|4|29|
|Purchase<br>of Equipment||||||107|107|143|
|Refurbishment<br>costs||||||22|22|38|
|Staff Education<br>and Welfare|||||18|52|70|178|
|Patient Welfare|||||4|37|41|10|
|Governance<br>Costs|||||18|19|37|37|
|Total expenditure|||||66|270|336|447|
|Net gain on investments||||13.1|56|62|118|233|
|Net income/(expenditure)|before transfers||||572|(1)|571|492|
|Transfers<br>between<br>funds||||16|4|(4)|||
|h/et movement<br>in funds||||18|576|(5)|571|492|
|Fund balances<br>brought|forward||at 1 April 2021||816|1,230|2,046|1,554|
|Fund balances carried|forward at 31 Nlerch 2022||||1,392|1,225|2,617|2,046|
|All gains and losses recognised|||in the year are|included|in the above statement.||||
|All amounts<br>relate to continuing|||operations.||||||
|The notes at pages 18|to 27|form part ofthese||financial|statements.||||





## 

## 

|Balance Sheet as|at 31 INarch 2022||||||
|---|---|---|---|---|---|---|
|||Note|Unrestrided|Restricted|Total at 31|Total at 31|
||||Funds|Funds|March 2022|March 2021|
||||8000|7000|6000|0000|
|Fixed Assets|||||||
|Investments||13|726|743|1.469|1,351|
|Total fixed assets|||726|743|1,469|1,351|
|Currant Assets|||||||
|Debtors and accrued income|||0|12|12|280|
|Cash and cash equivalents|||667|580|1,247|520|
|Total currenl assets|||667|592|1,259|800|
|Current<br>liabilities|||||||
|Creditors: Amounts|falling due||||||
|within one year||15||110||105|
|Net current assets|||666|482|1,148|695|
|Total assets less current liabilities|||1,392|1,225|2,617|2,046|
|Net Assets|||1.392|1,225|2,617|2,046|
|The funds ofthe Charity|||||||
|Restncted<br>income funds||||1,225|1,225|1,230|
|Unrestricted<br>income|funds||1,392||1,392|816|
|Total Charity Funds||19|1,392|1.225|2.617|2.D46|





## 

## 

||||||||Note|||
|---|---|---|---|---|---|---|---|---|---|
|||||||||2021/22|2020/21|
|||||||||f000|fODD|
|Cash flows from operating|||activities:|||||||
|hist cash used in operating|||activities||||16|686|25|
|Cash flows from investing|||activities:|||||||
|Dividends|and interest from||investments||||13.3|41|40|
|Proceeds|from sale ofinvestments|||||||||
|Net cash|provided<br>by investing<br>activities||||||||4D|
|Change|in cash and cash||equivalents|in the reporting||pedod||727|65|
|Increase|in cash and cash equivalents|||in the year||||727|65|
|Cash and|cash equivalents|at the beginning|||of|||||
|reporting|period|||||||520|455|
|Total cash and cash equivalents<br>at the end||||||||1,247|520|
|ofthe year||||||||||





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 


## 



## 

## 

||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|2021/22|2020/21|
||||EOOD|EOOD|EOOO|EOOO|
|Donations|||5|86|91|81|
|Fundraising|Income Generated|by Individuals|6|8|14|30|
|Grants Receivable|||25|2|27|173|
|Corporate|Donations||361|1|362|257|
|Gift Aid|||1|3|4|6|
|Legacies|||161||161|16|
|Tots I|||559|100|659|563|



## 

||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|2021/22|2020/21|
||||EOOO|EOOO|EOOO|EOOO|
|Income from|the provision||||||
|ofeducation|and training|||41|41|20|
|Total||||41|41|20|
|5.Other Trading Activities|||||||
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2021/22|2020/21|
||||EOOO|EOOO|EOOO|EOOO|
|Staff Lottery|deductions|||40|40|17|
|Fundraising|Events||||3||
|Total||||40|43|17|
|6. Other Incoming||Resources|||||
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|2021/22|2020/21|
||||EOOO|EOOO|EOOO|EOOO|
|Other Income||||5|5|66|
|Total|||||5|66|





## 

## 

|7.Raising|Funds||||
|---|---|---|---|---|
||||2021/22|2020/21|
||||6000|EOOO|
|Staff Lottery|Winnings|& Admin|28|12|
|Fundraising|Expenses||5||
|Fundraising|Salary Costs||22||
|Total|||55|12|



## 

|8.Charitable<br>activit|8.Charitable<br>activit|8.Charitable<br>activit|ies||||||
|---|---|---|---|---|---|---|---|---|
|The Charity pursued|||its charitable|activities|by making|grants,|shown|below by category.|
|||||||2021/22||2020/21|
|||||||EOOO||6000|
|Purchase|of Equipment|||||107||143|
|Research|Posts|and|Clinical Care||||4|29|
|Refurbishment<br>Costs & IT Equipment|||||||22|38|
|Staff Education||and Welfare|||||70|178|
|Patients|Welfare||||||41|10|
|Total||||||||398|



## 

## 




## 

## 

## 

|13.1 Movement<br>in|fixed asset|fixed asset|fixed asset|fixed asset|investment||2021/22|2020/21|
|---|---|---|---|---|---|---|---|---|
||||||||Total|Total|
||||||||EOOD|EOOD|
|hllarket<br>value brought||forward|||||1,351|1,118|
|Monies owed by CCLA for||||Chanaes|||10|10|
|Short term dividends|||||||(10)|(10)|
|Less disposals<br>at carrying||||value|||||
|Net gain on revaluation|||||||118|233|
|Market value at 31|March||||||1,489|1,351|
|13.2 Market value at||31 March|||||2021/22|2020/21|
||||||||Total|Total|
||||||||EOOD|EOOD|
|Held in UK|||||||||
|COIF Charities<br>Investment||||Fund|||1,469|1,351|
|Total|||||||1,469|1,351|
|The COIF Charities|Investment||||Fund includes|the following|investments:||
||||||||2021/22|2020/21|
|Asset agocation|||||||||
|Overseas<br>Equities|||||||64.13%|67.23%|
|Infrastructure<br>& Operating|||Assets||||9.06%|9.12%|
|Cash &near cash|||||||8.52%|4.83%|
|UK Equities|||||||850%|989%|
|Property|||||||4.58%|3.90%|
|Contractual<br>& Other|income||||||2.76%|2.68%|
|Private Equity & Other|||||||245%|20lo%%do|
|Fixed Interest||||||||0.34%|





## 

|13.3 Total gross income from invest|ments<br>and cash on deposit||
|---|---|---|
||2021/22|202D/21|
||Tote I|Total|
||EOOD|ROOD|
|Held in UK|||
|Investments|41||
|Total|41|40|



## 

## 

|14.Deb|tors|:|amou|nts|falling du|e within|one year|one year||
|---|---|---|---|---|---|---|---|---|---|
||||||||2021/22||2020/21|
|||||||||Total|Total|
|||||||||RDDO|EOOD|
|Dividend|Income|||||||11|10|
|Prepayments||||||||1|4|
|Accrued|Income||||||||266|
|Total|||||||||280|
|15.Creditors:|||amounts||falling due wtthin||one year|||
||||||||2021/22||2020/21|
|||||||||Total|Total|
|||||||||EODO|EOOD|
|Accruals||||||||81|64|
|Deferred|Income|||||||4|9|
|Amounts|owed||to hforth||Tees and|Hartlepool|NHS|18|32|
|Foundation||Trust||||||||
|Other creditors||||||||||
|Total|||||||||1D5|
|There is|no|security||for|non-trading|amounts|owed to the Foundation|Trust.||
|16. Transfers|||between||funds||202'I/22||2020/21|
|||||||||Total|Total|
|||||||||EOOD|ROOD|
|Transfers||||||||||





## 

## 

## 

## 

## 

|||||2021/22|2020/21|
|---|---|---|---|---|---|
|||||Total|Total|
|||||6000|OOOO|
|Net movement<br>in funds||||571|492|
|Gain on investments||||(118)|(233)|
|Deduct interest/dividends||income shown||||
|in investing<br>activities||||(41)|(40)|
|Decrease/(Increase)|in debtors|||268|(266)|
|increase<br>in creditors||||6|72|
|Net cash generated|from|operating|activities|686|25|





|||||||Annuai Report|Annuai Report|Annuai Report|Annuai Report|Annuai Report|and Accounts for North Tees|and Accounts for North Tees|and|Hart(spoof|NHS Foundal!on|NHS Foundal!on|NHS Foundal!on|NHS Foundal!on|Trust|Trust||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||General|Charitable||Fund||||||||||
||lit. Analysis||of||Charitable|||||Funds||||||||||||||
|||||||||||||||||Adjustment||for||||||
||||||||||||||||||balance|||||||
|||||||||||||||||movemenl|||of|||||
|||||||||||||||||uOnlatrlotild|furnla|||||||
|||||||||||||||||underandover||||||||
||||||||||||||Fund Balances||||625,0DO|||Incomilng|Resources|Irllemal|Fund Balances|
||||||||||||||at 31 March 2021|||at 31 March||2021||Resources|Expended|Transfers|at 31 March 2D22|
|||||||||||OsSCnpnOnOrthe<br>St meodpurpmesrme||||||||||||||
||ll~iiw|||||||||fund||||6000||||EODO||Eoao|6000|6000|r.DDO|
||Funds over||a5,000|||||||||||||||||||||
|||||||||||Tc SuPPOrl Patiem Care Wchln Ihe ClreCtarate||||||||||||||
|I|Me maria l|Fund||(cur||geiy||)||of Surgery||||51|||||||(3)||52|
|||||||||||Tosuppon pauent care within breast service||||||||||||||
|2 Breast Surgery||||Fund||||||indudlng|equipmenl<br>8 Iralning|||75|||||||(15)||66|
|||||||||||To support|patient care (or individuals|requinng||||||||||||
|3Speal Fund||||||||||treatment|vnthm Ihe Spnat Ceparlmenl|||48|||||||||50|
|||||||||||To support|patient cars fw Indivnlua<br>le|vnlh||||||||||||
|4|Haemalology||Fund|||||||blaod disorders||||124|||||||(3S)||I0D|
|||||||||||To suppod|paOenl care For indiwdua<br>le|||||||||||||
|5|UrologyResearchFund|||||||||dragnosed|with Urology/Krdneyrelaledillnets|||36|||||||||40|
|6|iMLegacy|Fund||||||||To sup perl the purchase<br>ofequip<br>ment <br>benefit<br>ol cancer<br>patients||fer Ihe||153||||||16|(17)||152|
|||||||||||To supped|palienl care for indiwduals|requmng||||||||||||
|7|Cardiology|Fu4d||||||||treatment|vnthln<br>the Cardiac unit|||116||||||14|(4)||126|
|||||||||||Tosupped|patient<br>care tor in Civduels|requiring||||||||||||
|a|Neo.Natal|||||||||treatment|within lhe neo-nels(<br>unit|||28|||||||(27)||12|
|||||||||||To support|atm ke patients<br>weaare and|staff||||||||||||
|9|Stroke Fund|||||||||training||||43|||||||(17)|||
|||||||||||To support|Coloredel<br>patient servces,|staff||||||||||||
|lo|Cnlcredal|Carioer Furid||||||||EduCalinn|6 Trasling|||30|||||||||31|
|il|hleonalal<br>Life||Supporl|||||||SupporlrunningofLife<br>Support course||||41||||||12|lgl||44|
|||||||||||Breasl Canrar nurae trainmg IVuelt*ra||ll||||||||||||
|tz|Breast Care Nurwng||||||Fund|||hardship<br>fund for patients||||ee||||||13|il8)||71|
|||||||||||To support|patient care for individuals|requlhmg||||||||||||
|13|Chematherapy||Fund|||||||treatment<br>wilhm<br>Chemotherapy<br>Fund UHNT||||53|||||||GD)||21|
||Funds Increased||||to||above|||525,000exat 31 March 2D22||||||||||||||
|14|Music v Cancer|||||||||||||||||24||2|(I)||25|
||Removed funds|||decreased||||||to below|f25 005as at 31 March 2022|||||||||||||
||||||||||To suppart||pedant care (ar individuals|||||||||||||
||||||||||requiring<br>lrealmenl<br>wilhla the neo.nate!|||||||||||||||
|Neo-Natal|||||||||snit||||||||(2ei|||(II)|27||(12)|
||||||||||TO SuPPOn||Patient<br>Care far indiVidus<br>IS requ turn 9|||||||||||||
|Chemotherapy|||Fund||||||treatment<br>within<br>Chemotherapy<br>Fund UHNT||||||||(53)|||(7)|39||i21)|
|Funds<br>at 31 March|||||2022|||||||||866|||(57)|||85|(113)||791|
|Other<br>Funds||balances|||||less||than 525 000as at 31stIrtarch 2022|||||||||57||174|(157)|(4)||
|Total<br>Restricted||||Funds||||||||||I 230||||||269|270||1 225|
|Total Unreslncled|||||Funds|||||||||816|||||||(66)|4|1,392|
|Toter Fund||balances|||||at31|||March 2022||||2,046||||||907|336l||2,517|



